Euro vs US Dollar

Überwachen Sie mehrere Echtzeitkurse von führenden Börsen wie NASDAQ, NYSE, AMEX, Bovespa und mehr.

Registrieren

NKTR Nektar Therapeutics

1,7908

0,1908 (11,93%)

11 Mai 2024 - Geschlossen

Verzögert um 15 Minuten

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]

Article too big to display. Click here to view on the SEC website

Nektar Therapeutics (NASDAQ:NKTR)
Historical Stock Chart
Von Apr 2024 bis Mai 2024

Click Here for more Nektar Therapeutics Charts.

Nektar Therapeutics (NASDAQ:NKTR)
Historical Stock Chart
Von Mai 2023 bis Mai 2024

Click Here for more Nektar Therapeutics Charts.

News Nektar Therapeutics

Form 8-K - Current report
Donnerstag 9 Mai 2024 (2 Tage vor) • Edgar (US Regulatory)

Nektar Therapeutics Reports First Quarter 2024 Financial Results
Donnerstag 9 Mai 2024 (2 Tage vor) • PR Newswire (US)

Nektar to Announce Financial Results for the First Quarter 2024 on Thursday, May 9, 2024, After Close of U.S.-Based Financial Markets
Freitag 3 Mai 2024 (1 Woche vor) • PR Newswire (US)

Nektar Management to Present at the H.C. Wainwright 2nd Annual Autoimmune & Inflammatory Disease Virtual Conference
Freitag 22 März 2024 (2 Monate vor) • PR Newswire (US)

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Dienstag 5 März 2024 (2 Monate vor) • Edgar (US Regulatory)

Nektar Therapeutics Announces Initiation of Phase 2b Clinical Study Evaluating Rezpegaldesleukin in Patients with Severe to Very Severe Alopecia Areata
Dienstag 5 März 2024 (2 Monate vor) • PR Newswire (US)

Form 8-K - Current report
Montag 4 März 2024 (2 Monate vor) • Edgar (US Regulatory)

Nektar Therapeutics Reports Fourth Quarter and Year-End 2023 Financial Results
Montag 4 März 2024 (2 Monate vor) • PR Newswire (US)

Form 8-K - Current report
Montag 4 März 2024 (2 Monate vor) • Edgar (US Regulatory)

Nektar Therapeutics Announces $30 Million Private Placement Financing with TCGX
Montag 4 März 2024 (2 Monate vor) • PR Newswire (US)

Nektar Management to Present at the TD Cowen 44th Annual Health Care Conference
Mittwoch 28 Februar 2024 (2 Monate vor) • PR Newswire (US)

Nektar to Announce Financial Results for the Fourth Quarter and Year-Ended 2023 on Monday, March 4, 2024, After Close of U.S.-Based Financial Markets
Dienstag 27 Februar 2024 (2 Monate vor) • PR Newswire (US)

Weitere Nektar Therapeutics News-Artikel

Gold vs US Dollar

BNP Paribas (QX)

Financial Select Sector

Energy Select Sector SPDR

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen